← Eichor
Study identifier: NCT06031688 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Condition: Recurrent Lung Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8  ·  Sponsor: SWOG Cancer Research Network

PhasePhase 2
Planned participants56
Who can joinAll sexes, 18 Minutes to no upper limit
Healthy volunteersNo

About this study

This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non-small cell lung cancer that has spread from where it first started (primary site) to other places in the body (stage IV) or that has come back after a period of improvement (recurrent). Tepotinib is used in patients whose cancer has a mutated (changed) form of a gene called MET. It is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal MET protein that signals tumor cells to multiply. This helps slow or stop the spread of tumor cells. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Giving tepotinib with ramucirumab may lower the chance of the cancer from growing or spreading in patients with stage IV or recurrent non-small cell lung cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (266)

Gulf Health Hospitals Inc/Infirmary Cancer Care - MalbisDaphne, Alabama, United StatesRecruiting
Thomas HospitalFairhope, Alabama, United StatesRecruiting
Mobile Infirmary Medical CenterMobile, Alabama, United StatesRecruiting
Gulf Health Hospitals Inc/Infirmary Cancer Care - SaralandSaraland, Alabama, United StatesRecruiting
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - JonesboroJonesboro, Arkansas, United StatesRecruiting
University of Arkansas for Medical SciencesLittle Rock, Arkansas, United StatesRecruiting
Kaiser Permanente-AnaheimAnaheim, California, United StatesActive Not Recruiting
Sutter Auburn Faith HospitalAuburn, California, United StatesRecruiting
Kaiser Permanente-Baldwin ParkBaldwin Park, California, United StatesActive Not Recruiting
Kaiser Permanente-BellflowerBellflower, California, United StatesActive Not Recruiting
Alta Bates Summit Medical Center-Herrick CampusBerkeley, California, United StatesRecruiting
Tower Cancer Research FoundationBeverly Hills, California, United StatesRecruiting

+ 254 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06031688